Frequency and determinants of use of immunosuppressants in the Australian Scleroderma Cohort Study
Immunosuppressant use is common in systemic sclerosis, with broadly similar determinants of usage among subtypes and autoantibody status. These real-world data suggest that disease-modifying anti-rheumatic drug use has increased, with earlier implementation of treatment, and a reduction in use of glucocorticoids.
Authors
- Laura Ross (ORCID: https://orcid.org/0000-0003-4636-729X)
- Mandana Nikpour (ORCID: https://orcid.org/0000-0002-6585-5611)
- Susanna Proudman (ORCID: https://orcid.org/0000-0002-3046-9884)
- Jessica L. Fairley (ORCID: https://orcid.org/0000-0003-4140-2711)
- Wendy Stevens
- Diane Apostolopoulos (ORCID: https://orcid.org/0000-0003-1078-6732)
- Lauren Host (ORCID: https://orcid.org/0000-0003-3480-7251)
- Dylan Hansen (ORCID: https://orcid.org/0000-0001-5777-7476)
- Gene-Siew Ngian
- Joanne Sahhar
- Jennifer Walker (ORCID: https://orcid.org/0000-0002-8197-4565)
Institutions
- The University of Sydney (AU)
- Royal Adelaide Hospital (AU)
- The University of Melbourne (AU)
- Flinders University (AU)
- Royal Prince Alfred Hospital (AU)
- Fiona Stanley Hospital (AU)
- St Vincent's Hospital Melbourne (AU)
- Monash Health (AU)
- Monash University (AU)
- The University of Adelaide (AU)
Publication Details
- Journal
- Journal of Scleroderma and Related Disorders
- Published
- 2025-05-22
- DOI
- https://doi.org/10.1177/23971983251342690
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Melbourne
- RACP Foundation
- National Health and Medical Research Council